Bayesian Design and Analysis (Clinical Regulatory Perspective) Celia Witten, Ph.D., M.D. Office Director, OCTGT, CBER, FDA FDA/ASA/Industry Statistics.
Monitoring and evaluation of IPV prevention programmes: lessons from the IMAGE and SASA! studies Charlotte Watts Ph.D. Department of Public Health and.
